Press Releases

Clinicians Trending toward Using Technology to Manage and Monitor Patient Treatment

30-Jul-08

Increasingly, health care clinicians are using technology to manage diseases and patients, according to Syd Stewart, managing director of UK-based 4S Information Systems Ltd.

Disease management programs were initially advocated by pharmaceutical companies in the1990s to provide value-added services to differentiate their drugs. When managed care organizations and outsourcing companies realised the potential of these programs to enhance patient management and reduce costs, they expanded the focus on specific diseases.  
 
Software such as Dawn Rheumatology (RH)—which is manufactured by 4S Information Systems Ltd.— is an important resource for clinicians seeking a better way to manage their patients’ medicine and treatment. For example, Anti-TNF drugs for the treatment of rheumatoid arthritis are expensive and their effectiveness needs close monitoring. Fulfillment of American College of Rheumatology (ACR) 50–70% improvement and European League Against Rheumatism (EULAR) good response or remission  [28-joint disease activity score (DAS28) <2.6] at three months are good outcome measures, according to Stewart.

“Dawn Rheumatology software has an integrated calculator/questionnaire module that can quickly derive these measures,” Stewart said. “The software has reports that permit ready tracking of these outcome measures such that it is easy to determine each patient's response with time."

Dawn RH was specially developed for the management of  patients suffering from rheumatologic disorders relating to the loco-motor system, including joints, muscles, connective tissues, and soft tissues around the joints and bones. With Dawn RH, rheumatologists can implement a safer, more organised way to manage patients and achieve better outcomes.
 
The software is easy to use, yet comprehensive, and it can be integrated with other information systems such as laboratory and patient administration. In addition, Dawn RH includes useful features such as scheduling dietary notes, self assessment forms, results monitoring and audit. Using Dawn RH to electronically monitor patients offers a number of benefits for clinicians and their patients. For instance, physicians can:

  • Automate many tasks to handle more patients with less time and effort
  • Optimise drug utilisations and recall dates by rapidly assessing disease activity
  • Receive trend detection alerts for test results or disease activity scores, improving the ability to monitor the state and progression of disease
  • Keep patients safer and healthier by standardising practices and maximising clinical accuracy
  • Easily extract data and analyze it to facilitate research, process improvement and disease management

 
While the use of clinical software is a growing trend, Dawn RH has been on the market for almost a decade. It has been used to treat thousands of UK patients at leading healthcare facilities such as St. Mary’s Hospital in London and Newcastle General Hospital in Newcastle-upon-Tyne. The software was recently introduced to the North American market.
 
Based in North West England, 4S Information Systems is a leading manufacturer of software for the health care industry. The company also offers anticoagulation management, anaemia patient tracking and hematology patient tracking software. Trading under the name 4S Dawn Clinical Software, the company maintains a staff of 14 and more than 300 customers in almost 20 different countries.
 
To learn more about how 4S Information Systems and Dawn RH are helping physicians leverage technology to improve patient care, please visit www.4s-dawn.com/dmard. Or contact Syd Stewart, managing director of 4S Information Systems Ltd., at 44 15395 63091.

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Latest Clinical Articles

Clinical Review - Renal colic

Contributed by Mr Ranan DasGupta, specialist registrar and Mr Jonathon Olsburgh, consultant urologic... Read more

Clinical Review - Stroke

By Dr Helen Hosker, GP and clinical commissioning lead for stroke, NHS Manchester, and Dr Pippa Tyrr... Read more

Sjogren's syndrome

Although it is one of the most common autoimmune diseases, Sjogren's syndrome remains underdiagnosed... Read more

Show all clinical articles

Latest News

GPC demands 4% practice income rise

The GPC has demanded a 4% rise in GMS income for 2009/10 to combat soaring expenses and inflation. Read more

Calculator allows GPs to work out if they will be contract winners

The GPC has published an online calculator to allow practices to work out if they will be winners or... Read more

NHS chief urges PCTs to 'interfere less' with PBC

PCTs should interfere less in practice-based commissioning (PBC), the NHS chief executive has warned... Read more

Babies born before peak flu season at higher asthma risk

Children born four months before peak flu season have a greater risk of developing asthma than those... Read more

MHRA issues faulty defibrillator warning

Defibrillators manufactured by Medtronic may fail to work because of a faulty internal cable, the Me... Read more

MIMS Product News

New drug - Intelence

Janssen-Cilag has launched Intelence (etravirine) for the treatment of HIV infection in antiretrovir... Read more

New drug - Doribax

Janssen-Cilag has launched Doribax (doripenem) for the treatment of nosocomial pneumonia (including ... Read more

Ebixa dosing made easier

Ebixa (memantine) is now licensed for once-daily administration in the treatment of patients with mo... Read more

Jobs

 

Job of the Week